No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy.
No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy.
复制标题
没有证据表明 X 连锁肾上腺脑白质营养不良患者造血细胞移植后肾上腺功能衰竭可逆转。
DOI:
10.1038/bmt.2012.33
复制
发表时间:
2012
影响因子:
4.8
通讯作者:
Orchard,PJ
中科院分区:
文献类型:
--
作者:
Petryk,A;Polgreen,LE;Chahla,S;Miller,W;Orchard,PJ
X-linked adrenoleukodystrophy (ALD) is a peroxisomal disorder characterized by accumulation of saturated very long-chain fatty acids (VLCFA) primarily in the adrenal cortex, central nervous system and testes. ALD results from mutations in the ABCD1 gene, which encodes a peroxisomal membrane transport protein. 1 The link between peroxisomal dysfunction and accumulation of VLCFA is not completely understood. Although impaired peroxisomal β-oxidation of VLCFA has been shown to have a role, mechanisms independent of the peroxisomal β-oxidation have also been proposed. 2The severity and tempo of progression of end-organ involvement vary among patients. Neurological disease is the most devastating manifestation, presenting either during childhood as rapidly progressive cerebral ALD or during adulthood as adrenomyeloneuropathy, a slowly progressive disease of the spinal cord, or both. Adrenal insufficiency (AI), either subclinical or overt, is found in the majority of patients with ALD, and may be present in up to 92% of children with cerebral disease. 3 Hematopoietic cell transplantation (HCT) is the only treatment definitively shown to halt neurological disease progression if performed early in the disease process. 4 Much less is known about the effects of HCT on adrenal function. The goal of this study was to examine if HCT can preserve normal adrenal function or reverse AI in ALD patients.